ZYDUSWELL
531335Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Mr. Kapil Sharma as Chief Revenue Officer forming part of Senior Management of the Company
Zydus Wellness Ltd, headquartered in Ahmedabad, India, is a leading consumer wellness company specializing in the development, manufacturing, and marketing of health and wellness products. The company’s diverse product portfolio spans segments such as nutrition, personal care, and skin care, with brands that enjoy strong recognition across India. Zydus Wellness is a part of the larger Zydus Group (Cadila Healthcare), giving it access to research and supply chain strengths across the pharmaceutical and consumer health spaces.
Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Mr. Kapil Sharma as Chief Revenue Officer forming part of Senior Management of the Company
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Disclosure under SEBI (PIT) Regulations, 2015
Announcement under Regulation 30 (LODR)-Credit Rating
Credit rating assigned by Care Ratings Limited
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Earnings Conference call held on August 4, 2026
ESG Rating
ESG rating received from Crisil
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investors' Conference to be held on August 14, 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication regarding unaudited financial results for the quarter ended on June 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of the Investor Call on unaudited financial results for the quarter ended on June 30, 2026
Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Independent Director
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 32nd AGM
Shareholder Meeting / Postal Ballot-Outcome of AGM
Voting Results
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer''s Report
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release
Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting
Unaudited Financial Results For The Quarter Ended On June 30, 2026
Unaudited financial results for the quarter ended on June 30, 2026
Zydus Wellness Ltd
About
Zydus Wellness Ltd, headquartered in Ahmedabad, India, is a leading consumer wellness company specializing in the development, manufacturing, and marketing of health and wellness products. The company’s diverse product portfolio spans segments such as nutrition, personal care, and skin care, with brands that enjoy strong recognition across India. Zydus Wellness is a part of the larger Zydus Group (Cadila Healthcare), giving it access to research and supply chain strengths across the pharmaceutical and consumer health spaces.
With a robust manufacturing footprint—including facilities in Sikkim and Gujarat—Zydus Wellness maintains stringent quality standards and drives innovation through dedicated R&D initiatives. The company distributes its products through an extensive network, comprising modern trade, e-commerce, and traditional retail channels, catering to both urban and rural markets across the country and, selectively, abroad.
Business Model & Strategy
Zydus Wellness operates primarily on a B2C (business-to-consumer) model, earning revenues from branded consumer products in categories such as sugar substitutes, nutrition supplements, skin care, and personal care. Iconic brands like Sugar Free, Complan, Glucon-D, Nycil, Everyuth, and Nutralite form the backbone of its business. The company drives growth via new product launches, market expansion initiatives, and portfolio innovation, often leveraging consumer health trends such as preventive wellness and natural ingredients.
Strategic pricing, wide distribution, and brand-building activities enable Zydus Wellness to maintain leadership in core categories and penetrate new markets.
The company’s growth vectors include expanding its rural reach, increasing digital and e-commerce penetration, and focusing on premium and value-added product lines. Ongoing investments in R&D support the introduction of differentiated offerings, while operational efficiencies and supply chain optimization contribute to steady margin improvement.
Management Overview
9 MembersMr.SHARVIL PANKAJ PATEL
Non-Executive - Non Independent Director-Chairperson related to PromoterMs.DHARMISHTA NARENDRAPRASAD RAVAL
Non-Executive - Independent DirectorUmeshParikh
Chief Financial OfficerMr.SRIVISHNU RAJU NANDYALA
Non-Executive - Independent DirectorMr.AKHIL ARUN MONAPPA
Non-Executive - Independent DirectorMr.KULIN SANJAY LALBHAI
Non-Executive - Independent DirectorMr.GANESH NARAYAN NAYAK
Non-Executive - Non Independent DirectorMr.TARUN GIAN ARORA
Executive Director-CEOMr.Nandish P. Joshi
Company Secretary & Compliance OfficerAwards & Recognition
5 Awards- Ranked among India’s Most Trusted Brands in health & wellness sector (Brand Trust Report 2024)
- Winner, Best Nutraceutical Brand for 'Sugar Free' (ET Brand Equity Awards 2024)
- Leadership award for sustainability initiatives in FMCG sector (2024, Frost & Sullivan)
- Certified Great Place to Work (2024)
- Recognized in Economic Times Best Brands List 2023
Market Information
Company Timeline
30+ Years of Excellence | 8 Major Milestones
Company incorporated as Carnation Nutra-Analogue Foods Ltd
Acquired by Cadila Healthcare (Zydus Group)
Renamed to Zydus Wellness Ltd
Launched Nutralite and Everyuth product extensions
Completed acquisition of Heinz India’s consumer wellness portfolio, including Complan, Glucon-D, Nycil, and Sampriti Ghee
Significant expansion of digital and e-commerce channels
Launched new value-added variants in Sugar Free and Complan; invested in green supply chain initiatives
Recognized for ESG and workplace excellence; expanded rural network and innovations pipeline
The Next Evolution
Contact Information
Registered Office
Scheme No. 63,, Zydus Corporate Park,, Survey No. 536,, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, Sarkhej
Tel: 079-4804000 / 71800000,
Fax: 079-67775811 / 26868337,
Email: nandish.joshi@zyduswellness.com
Website: zyduswellness.com
Corporate Actions
13| Purpose | Ex Date | Record Date | BC Start | BC End |
|---|---|---|---|---|
Final Dividend ₹1.20 per share | 17 Jul 2026 Friday | 17 Jul 2026 Friday | - | - |
Stock Split From Rs.10/- to Rs.2/- | 18 Sep 2025 Thursday | 18 Sep 2025 Thursday | - | - |
Final Dividend ₹6 per share | 11 Jul 2025 Friday | 11 Jul 2025 Friday | - | - |
Final Dividend ₹5 per share | 19 Jul 2024 Friday | 19 Jul 2024 Friday | - | - |
Final Dividend ₹5 per share | 21 Jul 2023 Friday | 21 Jul 2023 Friday | - | - |
Final Dividend ₹5 per share | 14 Jul 2022 Thursday | 15 Jul 2022 Friday | - | - |
Final Dividend ₹5 per share | 14 Jul 2021 Wednesday | - | 16 Jul 2021 Friday | 23 Jul 2021 Friday |
Interim Dividend ₹5 per share | 19 Mar 2020 Thursday | 21 Mar 2020 Saturday | - | - |
Final Dividend ₹5 per share | 17 Jul 2019 Wednesday | - | 19 Jul 2019 Friday | 31 Jul 2019 Wednesday |
Dividend ₹8 per share | 18 Jul 2018 Wednesday | - | 20 Jul 2018 Friday | 03 Aug 2018 Friday |
Interim Dividend ₹6.50 per share | 09 Mar 2017 Thursday | 10 Mar 2017 Friday | - | - |
Interim Dividend ₹6.50 per share | 16 Mar 2016 Wednesday | 17 Mar 2016 Thursday | - | - |
Dividend ₹6 per share | 16 Jul 2015 Thursday | - | 20 Jul 2015 Monday | 29 Jul 2015 Wednesday |
₹16,799 Cr.
₹522
₹612 / 368
19.1
₹183.11
2.89
₹27.68
₹2.00
0.23 %
Manage Ratio
FINANCIALS
| Annual Results | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | - | - | - | 882 | 1,778 | 1,876 | 2,020 | 2,260 | 2,342 | 2,723 | 3,967 | 3,892 |
| Expenses | - | - | - | 711 | 1,612 | 1,631 | 1,713 | 1,959 | 2,067 | 2,370 | 3,696 | 3,588 |
| Profit | - | - | - | 169 | 142 | 119 | 309 | 310 | 267 | 347 | 197 | 241 |
| Tax | - | - | - | -0.61 | -20.45 | -6.52 | -2.85 | -19.51 | -6.80 | 12 | 33 | 57 |
| EPS | - | - | - | 40 | 25 | 20 | 49 | 49 | 42 | 55 | 6 | 3.74 |
| Ratios | - |
Cash Flow
Consolidated Figures in Rs. Crores
| Annual Balance Sheet | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | - |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | - | - | - | 5,459 | 5,590 | 5,666 | 5,692 | 5,833 | 6,148 | 6,442 | 10,308 | - |
| Equity And Liabilities | - | - | - | 5,459 | 5,590 | 5,666 | 5,692 | 5,833 | 6,148 | 6,442 | 10,308 | - |
Shareholding Pattern
Numbers in Percentages
| Quarterly SHP Announcement Date | Mar 2016 12 Apr '16 | Mar 2017 31 Mar '17 | Mar 2018 31 Mar '18 | Mar 2019 15 Apr '19 | Mar 2020 08 Apr '20 | Mar 2021 06 Apr '21 | Mar 2022 06 Apr '22 | Mar 2023 07 Apr '23 | Mar 2024 08 Apr '24 | Mar 2025 12 Apr '25 | Mar 2026 01 May '26 | - |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Goverments | - | - | - | - | - | - | - | - | - | - | - | - |
| Promoter And Promoter Group | - | - | - | 67.62% | 67.82% | 64.82% | 64.82% | 66.45% | 69.62% | 69.63% | 69.63% | - |
| Non Institutions | - | - | - | 21.67% | 7.37% | 7.46% | 7.51% | 7.50% | 7.71% | 7.31% | 8.31% | - |
| FII | - | - | - | - | - | - | - | 3.87% | 3.26% | 3.29% | 3.18% | - |
| DII | - | - | - | - | - | - | - | 22.19% | 19.42% | 19.76% | 18.87% | - |
| Total | - | - | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - |
Zydus Wellness Ltd
Zydus Wellness Ltd
Zydus Wellness Ltd, headquartered in Ahmedabad, India, is a leading consumer wellness company specializing in the development, manufacturing, and marketing of health and wellness products. The company’s diverse product portfolio spans segments such as nutrition, personal care, and skin care, with brands that enjoy strong recognition across India. Zydus Wellness is a part of the larger Zydus Group (Cadila Healthcare), giving it access to research and supply chain strengths across the pharmaceutical and consumer health spaces.
With a robust manufacturing footprint—including facilities in Sikkim and Gujarat—Zydus Wellness maintains stringent quality standards and drives innovation through dedicated R&D initiatives. The company distributes its products through an extensive network, comprising modern trade, e-commerce, and traditional retail channels, catering to both urban and rural markets across the country and, selectively, abroad.
Zydus Wellness operates primarily on a B2C (business-to-consumer) model, earning revenues from branded consumer products in categories such as sugar substitutes, nutrition supplements, skin care, and personal care. Iconic brands like Sugar Free, Complan, Glucon-D, Nycil, Everyuth, and Nutralite form the backbone of its business. The company drives growth via new product launches, market expansion initiatives, and portfolio innovation, often leveraging consumer health trends such as preventive wellness and natural ingredients.
Strategic pricing, wide distribution, and brand-building activities enable Zydus Wellness to maintain leadership in core categories and penetrate new markets.
The company’s growth vectors include expanding its rural reach, increasing digital and e-commerce penetration, and focusing on premium and value-added product lines. Ongoing investments in R&D support the introduction of differentiated offerings, while operational efficiencies and supply chain optimization contribute to steady margin improvement.
Ranked among India’s Most Trusted Brands in health & wellness sector (Brand Trust Report 2024)
Winner, Best Nutraceutical Brand for 'Sugar Free' (ET Brand Equity Awards 2024)
Leadership award for sustainability initiatives in FMCG sector (2024, Frost & Sullivan)
Certified Great Place to Work (2024)
Recognized in Economic Times Best Brands List 2023
Company incorporated as Carnation Nutra-Analogue Foods Ltd
Acquired by Cadila Healthcare (Zydus Group)
Renamed to Zydus Wellness Ltd
Launched Nutralite and Everyuth product extensions
Completed acquisition of Heinz India’s consumer wellness portfolio, including Complan, Glucon-D, Nycil, and Sampriti Ghee
Significant expansion of digital and e-commerce channels
Launched new value-added variants in Sugar Free and Complan; invested in green supply chain initiatives
Recognized for ESG and workplace excellence; expanded rural network and innovations pipeline
Peer Comparison
| S.No. | Company Name | CMP (₹) | Market Cap (₹ Cr) | Div Yld (%) | NP Qtr (₹ Cr) | Qtr Profit Var (%) | Sales Qtr (₹ Cr) | Qtr Sales Var (%) | ROCE (%) | ROE (%) | Book Value (₹) | EPS TTM (₹) | TTMPE Ratio (₹) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Coming Soon
Heatmap View
Premium Feature| Company | CMP (₹) | MCap (₹ Cr) | EPS TTM (₹) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Financial Ratios
Premium Feature| Company Name | P/E (TTM) | EPS (₹) | D/E | NPM | GPM | ROE (%) | ROCE (%) | P/B | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Coming Soon